Previous studies have shown that the green tea-derived polyphenolic compound EGCG reduces Aβ production in both neuronal and mouse AD models in concert with activation of anti-amyloidogenic APP α-processing [14], [15], [18], [22]. This evidence concerns the gene APP and Alzheimer disease.